Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISE Study: Duavee in DCIS
NCT02694809Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jan 2017
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bazedoxifene in ductal carcinoma in situ (DCIS), sponsored by Northwestern University. Started Jan 2017; status: completed.
02
Drugs
bazedoxifene
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT02694809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02694809.